INVO Fertility (NASDAQ:IVF) Announces Quarterly Earnings Results

INVO Fertility (NASDAQ:IVF – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($2.44) EPS for the quarter, FiscalAI reports. The firm had revenue of $2.22 million for the quarter. INVO Fertility had a negative net margin of 116.29% and a negative return on equity of 85.54%.

INVO Fertility Stock Performance

NASDAQ:IVF opened at $2.60 on Monday. The business’s 50-day moving average price is $10.43 and its two-hundred day moving average price is $31.57. INVO Fertility has a twelve month low of $1.59 and a twelve month high of $91.60. The stock has a market cap of $1.64 million, a P/E ratio of -0.02 and a beta of 2.42. The company has a quick ratio of 0.67, a current ratio of 0.71 and a debt-to-equity ratio of 0.03.

Wall Street Analyst Weigh In

Several analysts have issued reports on IVF shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of INVO Fertility in a research note on Friday, October 30th. Wall Street Zen upgraded shares of INVO Fertility to a “hold” rating in a research report on Saturday, August 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, INVO Fertility currently has an average rating of “Moderate Buy” and an average target price of $320.00.

Check Out Our Latest Stock Report on INVO Fertility

About INVO Fertility

(Get Free Report)

INVO Fertility, Inc. is a commercial-stage fertility company focused on expanding access to assisted reproductive technology. The company develops and commercializes fertility products and services designed to provide alternatives to conventional in vitro fertilization (IVF) treatment. Its principal product is INVOcell, a medical device used in the INVO Procedure. The system allows early-stage embryo incubation to take place inside the patient’s body rather than in a conventional laboratory incubator, while still involving the retrieval of eggs, fertilization, and subsequent embryo transfer under the supervision of fertility professionals.

Read More

Earnings History for INVO Fertility (NASDAQ:IVF)

Receive News & Ratings for INVO Fertility Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Fertility and related companies with MarketBeat.com's FREE daily email newsletter.